Correlation Between Allogene Therapeutics and Iteos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Iteos Therapeutics, you can compare the effects of market volatilities on Allogene Therapeutics and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Iteos Therapeutics.
Diversification Opportunities for Allogene Therapeutics and Iteos Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Allogene and Iteos is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Iteos Therapeutics go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Iteos Therapeutics
Given the investment horizon of 90 days Allogene Therapeutics is expected to generate 2.11 times more return on investment than Iteos Therapeutics. However, Allogene Therapeutics is 2.11 times more volatile than Iteos Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 268.00 in Allogene Therapeutics on August 29, 2024 and sell it today you would lose (18.00) from holding Allogene Therapeutics or give up 6.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. Iteos Therapeutics
Performance |
| Timeline |
| Allogene Therapeutics |
| Iteos Therapeutics |
Allogene Therapeutics and Iteos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Iteos Therapeutics
The main advantage of trading using opposite Allogene Therapeutics and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |